In a recent 24-week, placebo-controlled study, vildagliptin 50 mg significantly reduced HbA1c in 449 patients with T2DM who were inadequately controlled by basal or premixed insulin (about 40 U/day) with or without metformin [12]. The gene discussed is INS; the disease is type 2 diabetes mellitus.